354 related articles for article (PubMed ID: 30721706)
1. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.
Kia V; Mortazavi Y; Paryan M; Biglari A; Mohammadi-Yeganeh S
Life Sci; 2019 Mar; 220():162-168. PubMed ID: 30721706
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
6. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-10b sponge: An anti-breast cancer study in vitro.
Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
[TBL] [Abstract][Full Text] [Related]
11. Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.
Li XJ; Ren ZJ; Tang JH; Yu Q
Cell Physiol Biochem; 2017; 44(5):1741-1748. PubMed ID: 29216623
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.
Gong L; Bao Q; Hu C; Wang J; Zhou Q; Wei L; Tong L; Zhang W; Shen Y
Biochem Biophys Res Commun; 2018 Jun; 500(2):170-176. PubMed ID: 29626470
[TBL] [Abstract][Full Text] [Related]
13. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.
Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J
Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922
[TBL] [Abstract][Full Text] [Related]
15. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
[TBL] [Abstract][Full Text] [Related]
16. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
[TBL] [Abstract][Full Text] [Related]
17. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.
Sun L; He M; Xu N; Xu DH; Ben-David Y; Yang ZY; Li YJ
Int J Oncol; 2018 Dec; 53(6):2705-2714. PubMed ID: 30272274
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.
Wei Y; Lai X; Yu S; Chen S; Ma Y; Zhang Y; Li H; Zhu X; Yao L; Zhang J
Breast Cancer Res Treat; 2014 Sep; 147(2):423-31. PubMed ID: 25007959
[TBL] [Abstract][Full Text] [Related]
19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
20. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
Haug BH; Hald ØH; Utnes P; Roth SA; Løkke C; Flægstad T; Einvik C
Anticancer Res; 2015 May; 35(5):2521-30. PubMed ID: 25964525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]